Short CV
Professional appointments
- Professor in general practice in general practice with main focus on addiction research and clinical epidemiology at Heinrich-Heine University Düsseldorf (D), with honorary appointments at:
- Maastricht University (NL)
- University College London (UK)
- University of Edinburgh (UK)
Training and education (selection)
- PhD degree, Maastricht University, 2008
- Master’s degree Epidemiology (cum laude), Maastricht University, 2006
- Master’s degree Health Sciences, Maastricht University, 2003
- Diploma Physiotherapy, University of Professional Education Arnhem and Nijmegen, 2000
Management positions and memberships (selection)
- Head, Addiction Research and Clinical Epidemiology unit, 2015-present (www.uniklinik-duesseldorf.de)
- Board member and (Past-)President, Society for Research on Nicotine and Tobacco Europe, 2018-2020 (www.srnteurope.eu)
- Co-founder and member of the steering committee, Netherlands Network of Tobacco Research, 2013-present (www.nnvt.org)
- Member, International Primary Care Research Leadership Programme, 2008-present (www.phc.ox.ac.uk)
Main research interests
- Tobacco addiction: effectiveness of behavioural and pharmacological treatments
- Chronic obstructive pulmonary disease (COPD): prediction modelling, early detection, prevention
- Clinical epidemiology: research methodology and reporting
Current major funding programs
- German Federal Ministry of Health (BMG): “German Study on Tobacco Use (DEBRA-II)” (PI: €422,064)
- German Federal Ministry of Education and Research (BMBF): “NRW General Practice Research Network” (Co-PI: €3,750,000)
- EU Horizon 2020: “Tobacco cessation within TB programmes” (Co-PI: €2,999,829)
- German Federal Ministry of Health (BMG): “Training general practitioners in brief stop-smoking advice” (PI: €399,804)
- NRW Ministry for Innovation, Science and Research: “Treating tobacco addiction: new clinical approaches” (PI: €1,250,000)
Contributions to scientific meetings (selection)
- Keynote lecture: Society for Research on Nicotine and Tobacco (SRNT) Europe, online, 17-09-2020
- Scientific program committee chair: Society for Research on Nicotine and Tobacco (SRNT) Europe, Munich (D), 06-09-2018
- Scientific program committee: German Society for General Practice and Family Medicine (DEGAM). Düsseldorf (D): 21-09-2017
- Conference co-chair: Society for Research on Nicotine and Tobacco (SRNT), Florence (IT), 08-03-2017
Editorial work and review
- Senior Editor of Addiction, 2013-present (www.addictionjournal.org)
- Associate Editor of the Journal of Clinical Epidemiology, 2009-2017, Editorial Board member 2018-present (www.jclinepi.com)
- Expert reviewer for 48 different journals (incl. Ann Intern Med, BMJ, ERJ, Lancet ) and 12 different funding agencies
Awards (selection)
- Lothar Beyer Research Award of the German Foundation of General Practice and Family Medicine (3rd prize), 2019
- Pharmacoepidemiology and Drug Safety Best Reviewer Award, 2013
- Netherlands School for Primary Care Research Lecturer of the Year Award, 2010
- European Respiratory Society Young Scientist Sponsorship, 2008
Key publications
- Dogar O, Keding A, […] Kotz D et al. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Global Health. 2020;8(11):e1408-e1417.
- Kotz D, Böckmann M, Kastaun S. The use of tobacco, e-cigarettes, and methods to quit smoking in Germany—a representative study using 6 waves of data over 12 months (the DEBRA study). Dtsch Arztebl Int 2018; 115:235-242
- van Rossem C, […] Kotz D. Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation. Addiction 2017; 112:2237-2247
- Kotz D, Viechtbauer W, Simpson C, et al. Cardiovascular and Neuropsychiatric Risks of Varenicline: a retrospective cohort study using a national general practice database The Lancet Respiratory Medicine; 2015;3(10):761-768.
- Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109:1531-1540
- Kotz D, Wesseling GJ, Huibers MJH, van Schayck CP. Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J 2009; 33:754-762
- Kotz D, West R. Explaining the social gradient in smoking cessation: it’s not in the trying but in the succeeding. Tob Control 2009; 18: 43-46